Protalix BioTherapeutics Issues Statement Related to Silicon Valley Bank and Signature Bank ...Middle East

PR Newswire - News
Protalix BioTherapeutics Issues Statement Related to Silicon Valley Bank and Signature Bank
CARMIEL, Israel, March 13, 2023 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX) (TASE:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell...

Hence then, the article about protalix biotherapeutics issues statement related to silicon valley bank and signature bank was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Protalix BioTherapeutics Issues Statement Related to Silicon Valley Bank and Signature Bank )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News